Indaptus Therapeutics Earnings
NASDAQ: INDPHealthcareBiotechnologyUSD
2.44-0.07 (-2.79%)
At close: Oct 12, 4:00 PM ET · Delayed 15 min
Next earnings date
Wed, Nov 11, 2026
Fiscal period
Sep/2026
Indaptus Therapeutics earnings summary
Indaptus Therapeutics is scheduled to report Sep/2026 earnings on Nov 11, 2026. In its most recent report on Aug 13, 2026 (Q2 2026), INDP posted EPS of $-0.02. Across the last 16 reports, INDP shares moved an average of 11.8% (in either direction) in the first trading session after results, rising 7 times and falling 9 times.
Summary generated from market data by MetaCap's automated system. Methodology
INDP earnings history
| Report date | EPS est. | EPS actual | Surprise | Price reaction |
|---|---|---|---|---|
| Aug 13, 2026 | — | $-0.02 | — | +20.6% |
| May 15, 2026 | — | $-0.23 | — | -23.3% |
| Mar 17, 2026 | — | $-0.40 | — | +4.7% |
| Nov 12, 2025 | — | $-2.98 | — | -26.3% |
| Aug 13, 2025 | — | $-9.09 | — | +3.2% |
| May 14, 2025 | — | $-9.11 | — | -17.8% |
| Mar 13, 2025 | — | $-22.31 | — | -10.6% |
| Nov 12, 2024 | — | $-9.04 | — | -9.9% |
| Aug 12, 2024 | — | $-13.16 | — | -1.2% |
| May 8, 2024 | — | $-0.45 | — | +7.4% |
| Mar 13, 2024 | — | $-0.46 | — | +24.1% |
| Nov 6, 2023 | — | $-0.47 | — | -11.6% |
| Aug 14, 2023 | — | $-0.39 | — | -4.5% |
| May 11, 2023 | — | $-0.51 | — | +0.7% |
| Mar 17, 2023 | — | $-0.44 | — | +17.3% |
| Nov 10, 2022 | — | $-0.42 | — | -5.0% |
Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.